Innovation
40 patent families (32 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 5,555 times.
| Year | Filings |
|---|---|
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 13 |
| 2020 | 14 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 16 |
| 2024 | 20 |
| 2025 | 16 |
| 2026 | 4 |
Social engagement
Social engagement: 1.6K social following, 6 posts in the last 12 months — top 10% of its industry.
Investor mix
14 investors on record; lead investors include HC2 Holdings, Huadong Medicine.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 29% |
| Private equity | 4 | 29% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 5 | 36% |
Recent activity
23 Jun 2026
Event
MediBeacon Transdermal GFR System Application and Clinical Practice
18 Jun 2026
Event
Webinar on Applications and Clinical Practice of the MediBeacon Transdermal GFR System
10 Jun 2026
Event
MediBeacon Transdermal GFR System Applications and Clinical Practice